You might only need a headline and a short paragraph from one of those PRs to "get an idea of how "Hedge Funds" operate".
Cellceutix Announces Dismissal of Class Action Lawsuit Filed by Rosen Law Firm
Corporate
BEVERLY, MA--(Marketwired - June 09, 2016) - Cellceutix Corporation (CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to announce that, yesterday, the U.S. District Court for the Southern District of New York granted the Company's motion to dismiss the securities class action lawsuit brought against the Company by a plaintiff represented by the Rosen Law Firm.